Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-24-003930
Filing Date
2024-02-13
Accepted
2024-02-13 16:52:47
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 vtgn20240209_s3.htm S-3 562179
2 EXHIBIT 4.2 ex_625288.htm EX-4.2 421195
3 EXHIBIT 5.1 ex_625617.htm EX-5.1 56504
4 EXHIBIT 23.2 ex_625289.htm EX-23.2 2830
5 EXHIBIT FILING FEES ex_624961.htm EX-FILING FEES 81590
6 vistalogo.jpg GRAPHIC 22429
7 woodburn02.jpg GRAPHIC 20256
8 woodburnlogo.jpg GRAPHIC 27165
  Complete submission text file 0001437749-24-003930.txt   1221196
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: S-3 | Act: 33 | File No.: 333-277041 | Film No.: 24627022
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)